Literature DB >> 21426319

PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB.

T Aoki1, M Nishimura, T Matsuoka, K Yamamoto, T Furuyashiki, H Kataoka, S Kitaoka, R Ishibashi, A Ishibazawa, S Miyamoto, R Morishita, J Ando, N Hashimoto, K Nozaki, S Narumiya.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral aneurysm is a frequent cerebrovascular event and a major cause of fatal subarachnoid haemorrhage, but there is no medical treatment for this condition. Haemodynamic stress and, recently, chronic inflammation have been proposed as major causes of cerebral aneurysm. Nevertheless, links between haemodynamic stress and chronic inflammation remain ill-defined, and to clarify such links, we evaluated the effects of prostaglandin E(2) (PGE(2) ), a mediator of inflammation, on the formation of cerebral aneurysms. EXPERIMENTAL APPROACH: Expression of COX and prostaglandin E synthase (PGES) and PGE receptors were examined in human and rodent cerebral aneurysm. The incidence, size and inflammation of cerebral aneurysms were evaluated in rats treated with COX-2 inhibitors and mice lacking each prostaglandin receptor. Effects of shear stress and PGE receptor signalling on expression of pro-inflammatory molecules were studied in primary cultures of human endothelial cells (ECs). KEY
RESULTS: COX-2, microsomal PGES-1 and prostaglandin E receptor 2 (EP(2) ) were induced in ECs in the walls of cerebral aneurysms. Shear stress applied to primary ECs induced COX-2 and EP(2) . Inhibition or loss of COX-2 or EP(2) in vivo attenuated each other's expression, suppressed nuclear factor κB (NF-κB)-mediated chronic inflammation and reduced incidence of cerebral aneurysm. EP(2) stimulation in primary ECs induced NF-κB activation and expression of the chemokine (C-C motif) ligand 2, essential for cerebral aneurysm. CONCLUSIONS AND IMPLICATIONS: These results suggest that shear stress activated PGE(2) -EP(2) pathway in ECs and amplified chronic inflammation via NF-κB. We propose EP(2) as a therapeutic target in cerebral aneurysm.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21426319      PMCID: PMC3144537          DOI: 10.1111/j.1476-5381.2011.01358.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

Review 1.  Prostanoid receptors: structures, properties, and functions.

Authors:  S Narumiya; Y Sugimoto; F Ushikubi
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

2.  Experimentally induced cerebral aneurysms in rats: Part V. Relation of hemodynamics in the circle of Willis to formation of aneurysms.

Authors:  N Hashimoto; H Handa; I Nagata; F Hazama
Journal:  Surg Neurol       Date:  1980-01

3.  Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms.

Authors:  D R Holmes; W Wester; R W Thompson; J M Reilly
Journal:  J Vasc Surg       Date:  1997-05       Impact factor: 4.268

4.  Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase.

Authors:  M Miralles; W Wester; G A Sicard; R Thompson; J M Reilly
Journal:  J Vasc Surg       Date:  1999-05       Impact factor: 4.268

5.  Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells.

Authors:  J F Schmedtje; Y S Ji; W L Liu; R N DuBois; M S Runge
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

6.  Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.

Authors:  J N Topper; J Cai; D Falb; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

7.  Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

Authors:  Takuya Kobayashi; Yoshio Tahara; Mayumi Matsumoto; Masako Iguchi; Hideto Sano; Toshinori Murayama; Hidenori Arai; Hiroji Oida; Takami Yurugi-Kobayashi; Jun K Yamashita; Hiroyuki Katagiri; Masataka Majima; Masayuki Yokode; Toru Kita; Shuh Narumiya
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Experimentally induced cerebral aneurysms in rats.

Authors:  N Hashimoto; H Handa; F Hazama
Journal:  Surg Neurol       Date:  1978-07

9.  Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms.

Authors:  Nobutake Sadamasa; Kazuhiko Nozaki; Nobuo Hashimoto
Journal:  Stroke       Date:  2003-11-13       Impact factor: 7.914

10.  Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis.

Authors:  F H Linn; G J Rinkel; A Algra; J van Gijn
Journal:  Stroke       Date:  1996-04       Impact factor: 7.914

View more
  58 in total

Review 1.  Flow-induced, inflammation-mediated arterial wall remodeling in the formation and progression of intracranial aneurysms.

Authors:  Juhana Frösen; Juan Cebral; Anne M Robertson; Tomohiro Aoki
Journal:  Neurosurg Focus       Date:  2019-07-01       Impact factor: 4.047

2.  Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism.

Authors:  Jia Liu; Atsushi Kuwabara; Yoshinobu Kamio; Shuling Hu; Jeonghyun Park; Tomoki Hashimoto; Jae-Woo Lee
Journal:  Stem Cells       Date:  2016-07-08       Impact factor: 6.277

3.  MicroRNA and gene expression changes in unruptured human cerebral aneurysms.

Authors:  Kimon Bekelis; Joanna S Kerley-Hamilton; Amy Teegarden; Craig R Tomlinson; Rachael Kuintzle; Nathan Simmons; Robert J Singer; David W Roberts; Manolis Kellis; David A Hendrix
Journal:  J Neurosurg       Date:  2016-02-26       Impact factor: 5.115

4.  Endovascular biopsy: Technical feasibility of novel endothelial cell harvesting devices assessed in a rabbit aneurysm model.

Authors:  Daniel L Cooke; Diana Bauer; Zhengda Sun; Carol Stillson; Jeffrey Nelson; David Barry; Steven W Hetts; Randall T Higashida; Christopher F Dowd; Van V Halbach; Hua Su; Maythem M Saeed
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

5.  Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture.

Authors:  David M Hasan; Kelly B Mahaney; Robert D Brown; Irene Meissner; David G Piepgras; John Huston; Ana W Capuano; James C Torner
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

6.  Two Diverse Hemodynamic Forces, a Mechanical Stretch and a High Wall Shear Stress, Determine Intracranial Aneurysm Formation.

Authors:  Hirokazu Koseki; Haruka Miyata; Satoshi Shimo; Nobuhiko Ohno; Kazuma Mifune; Kenjiro Shimano; Kimiko Yamamoto; Kazuhiko Nozaki; Hidetoshi Kasuya; Shuh Narumiya; Tomohiro Aoki
Journal:  Transl Stroke Res       Date:  2019-02-08       Impact factor: 6.829

Review 7.  Role of fluid dynamics and inflammation in intracranial aneurysm formation.

Authors:  Alexis S Turjman; Francis Turjman; Elazer R Edelman
Journal:  Circulation       Date:  2014-01-21       Impact factor: 29.690

Review 8.  High wall shear stress and spatial gradients in vascular pathology: a review.

Authors:  Jennifer M Dolan; John Kolega; Hui Meng
Journal:  Ann Biomed Eng       Date:  2012-12-11       Impact factor: 3.934

Review 9.  The role of oxidative stress in cerebral aneurysm formation and rupture.

Authors:  Robert M Starke; Nohra Chalouhi; Muhammad S Ali; Pascal M Jabbour; Stavropoula I Tjoumakaris; L Fernando Gonzalez; Robert H Rosenwasser; Walter J Koch; Aaron S Dumont
Journal:  Curr Neurovasc Res       Date:  2013-08       Impact factor: 1.990

10.  Association between NFKB1 -94 insertion/deletion ATTG polymorphism and risk of intracranial aneurysm.

Authors:  Xiutian Sima; Jianguo Xu; Jin Li; Chao You
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.